EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients

Javed Butler, Sanjiv J. Shah, Melissa Magwire, Carlos Campos, Muhammad Shariq Usman, Anthony Hoovler, Anup Sabharwal, Barry A. Borlaug

Global Cardiology · 28.06.2024 · 2 (2)

DOI: 10.4081/cardio.2024.38 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Cardiology, online erschienen am 28.06.2024. Verfasst von Javed Butler und 7 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity, highly prevalent in patients with heart failure with preserved ejection fraction (HFpEF), may make HFpEF more difficult to diagnose by masking its signs. The aim of this study was to identify challenges patients and healthcare professionals (HCPs) face in diagnosing and treating patients with HFpEF and obesity.

Methods

An anonymous, US populationbased online survey was conducted in September 2020 among 114 patients with obesity and a selfreported diagnosis of HFpEF and 200 HCPs.

Results

In the typical medical journey, almost half of patients (45%) were diagnosed with HFpEF within one month of discussing symptoms with an HCP; however, the remaining patients waited an average of 22 months for diagnosis, most of whom (78%) received their diagnosis from a cardiologist. Most patients (65%) perceived their cardiologist as the coordinator of their HFpEF care. The treatments most recommended by cardiologists for the ongoing treatment of HFpEF included lifestyle changes (91%), diuretics (87%), beta blockers (76%), and angiotensinconverting enzyme inhibitors (71%). Heart failure specialists (29%) were more likely than general cardiology specialists (12%) to report recommending prescription weightloss medications for management of HFpEF. Most cardiologists reported not having received formal training in obesity management.

Conclusions

Cardiology specialists play a central role in the diagnosis and management of HFpEF, but optimal coordination is needed to improve obesity management in patients with HFpEF.

Zitieren

APA

Butler, J., Shah, S. J., Magwire, M., Campos, C., Usman, M. S., Hoovler, A., Sabharwal, A., & Borlaug, B. A. (2024). Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients. Global Cardiology, 2(2). https://doi.org/10.4081/cardio.2024.38

Vancouver

Butler J, Shah SJ, Magwire M, Campos C, Usman MS, Hoovler A, et al. Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients. Global Cardiology. 2024;2(2). doi:10.4081/cardio.2024.38

BibTeX
@article{Butler2024,
  author = {Butler, Javed and Shah, Sanjiv J. and Magwire, Melissa and Campos, Carlos and Usman, Muhammad Shariq and Hoovler, Anthony and Sabharwal, Anup and Borlaug, Barry A.},
  title = {Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients},
  journal = {Global Cardiology},
  year = {2024},
  volume = {2},
  number = {2},
  doi = {10.4081/cardio.2024.38}
}
Kostenlos starten →